One (1) Cobas Liat Assays Analyzer, Associated PCR Kits, and Comprehensive Maintenance
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast is planning to award a firm-fixed-price, sole-source contract to Roche Diagnostics for the procurement of one Cobas Liat Assays Analyzer, associated PCR kits, and comprehensive maintenance services. This acquisition will be conducted under the Federal Acquisition Regulation provision allowing sole-source contracts when only one responsible source can fulfill the agency’s requirements. This notice is informational only; it is not a solicitation or a request for competitive proposals, and no solicitation package is available. The contract relates to medical diagnostic equipment and support, specifically for use at Charleston Air Force Base in South Carolina. The acquisition falls under the NAICS code 621511, indicating health-related services. Interested parties cannot submit proposals or inquiries regarding this notice. The point of contact for this procurement is Lenore Y. Paseda, with Rebecca Brashears serving as a secondary contact. The notice affirms that no set-aside applies and emphasizes the exclusive relationship with Roche Diagnostics to meet the agency's specialized needs.
General Info
Agency
NAICS
Place of Performance
Charleston AFB, SC, 29152, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
NOTICE OF INTENT TO SOLE SOURCE:
This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. No solicitation package is available, and telephone requests will not be honored. Only one responsible source, and no other supplies or services will satisfy agency requirements.
The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) provides notice of its intent to award a firm-fixed-price, sole-source contract to Roche Diagnostics. This notice is not a request for competitive proposals; no solicitation package is available, and telephone requests will not be honored. The acquisition is conducted under the authority of Federal Acquisition Regulation (FAR) 6.302-1, "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements."
Reference the attached Notice of Intent (NOI)
